Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesoblast (MESO) Liabilities and Shareholders Equity: 2015-2024

Historic Liabilities and Shareholders Equity for Mesoblast (MESO) over the last 8 years, with Dec 2024 value amounting to $653.3 million.

  • Mesoblast's Liabilities and Shareholders Equity fell 2.53% to $653.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $2.7 billion, marking a year-over-year increase of 0.15%. This contributed to the annual value of $669.2 million for FY2024, which is 0.04% down from last year.
  • Per Mesoblast's latest filing, its Liabilities and Shareholders Equity stood at $653.3 million for Q4 2024, which was down 2.37% from $669.2 million recorded in Q2 2024.
  • Mesoblast's 5-year Liabilities and Shareholders Equity high stood at $766.1 million for Q1 2021, and its period low was $650.4 million during Q1 2023.
  • Moreover, its 3-year median value for Liabilities and Shareholders Equity was $669.2 million (2024), whereas its average is $667.7 million.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first grew by 15.07% in 2021, then fell by 11.09% in 2022.
  • Quarterly analysis of 5 years shows Mesoblast's Liabilities and Shareholders Equity stood at $687.3 million in 2020, then rose by 2.49% to $704.4 million in 2021, then fell by 5.16% to $668.1 million in 2022, then increased by 0.33% to $670.3 million in 2023, then declined by 2.53% to $653.3 million in 2024.
  • Its last three reported values are $653.3 million in Q4 2024, $669.2 million for Q2 2024, and $670.3 million during Q4 2023.